Tag: Grifols

The global albumin market exceeded $5 billion in 2021, reflecting its importance in critical care and biopharmaceuticals. Deciding which company's albumin is best is not a simple choice, as manufacturers differ significantly in their source material and production methods.

The global albumin market is dominated by a handful of key players, with major pharmaceutical and biotechnology firms manufacturing albumin from human plasma or through recombinant technology. This vital medication supports many medical applications, from critical care to disease management. Let's explore who manufactures albumin and the intricate processes involved in its production.